Antidepressant therapy with moclobemide
β
J. Angst; J.-P. Gachoud; U. E. Gasser; M. KΓΆhler
π
Article
π
1993
π
John Wiley and Sons
π
English
β 558 KB
A Swiss, open, mdticentre clinical study was conducted in collaboration with 176 general practitioners and internists to evaluate the efficacy and tolerability of moclobemide, an antidepressant belonging to a class of novel reversible MAO-A inhibitors called RIMAs. Six hundred and fifty-four outpati